Questions about this study?
The HopeStage team will email you.
Get research updatesThis historical record does not confirm current site availability.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This study is for healthy volunteers. Other eligibility criteria apply.
This is historical registry information. What is the current study status and protocol?
Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers
The HopeStage team will email you.
Germany
A listed location does not confirm current availability.
The study sponsor is Zentralinstitut für Seelische Gesundheit Mannheim.
This study is for healthy volunteers. Other eligibility criteria apply.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me